(18)F-FMISO PET Imaging Identifies Hypoxia and Immunosuppressive Tumor Microenvironments and Guides Targeted Evofosfamide Therapy in Tumors Refractory to PD-1 and CTLA-4 Inhibition

por Reeves, Kirsten M., Song, Patrick N., Angermeier, Allyson, Manna, Deborah Della, Li, Yufeng, Wang, Jianbo, Yang, Eddy S., Sorace, Anna G., Larimer, Benjamin M.
Publicado 2022

RNF2 ablation reprograms the tumor-immune microenvironment and stimulates durable NK and CD4(+) T-cell-dependent antitumor immunity

por Zhang, Zhuo, Luo, Lin, Xing, Chuan, Chen, Yu, Xu, Peng, Li, Mao, Zeng, Ling, Li, Chao, Ghosh, Sadashib, Manna, Deborah Della, Townes, Tim, Britt, William J., Wajapeyee, Narendra, Sleckman, Barry P., Chong, Zechen, Wu Leavenworth, Jianmei, Yang, Eddy S
Publicado 2021